Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies

International Journal of Drug Policy

Volumn 21, Issue 1, 2010, Pages 10-19

  McLaren, Jennifer A ^a   Silins, Edmund ^a   Hutchinson, Delyse ^a   Mattick, Richard P ^a   Hall, Wayne ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cannabis; Causal relation; Cohort; Methodology; Psychosis; Schizophrenia

Indexed keywords

CANNABIS;

CANNABIS ADDICTION; CAUSAL ATTRIBUTION; COHORT ANALYSIS; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; INCIDENCE; INTOXICATION; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SHORT SURVEY; VULNERABLE POPULATION;

CAUSALITY; COHORT STUDIES; DISEASE SUSCEPTIBILITY; DRUG AND NARCOTIC CONTROL; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; MARIJUANA SMOKING; PSYCHOTIC DISORDERS;

EID: 71149110702     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.09.001     Document Type: Short Survey

References (76)

1. Agosti V., Nunes E., and Levin F. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. American Journal of Drug and Alcohol Abuse 28 (2002) 643
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., text revision (DSM-IV-TR) (2000), American Psychiatric Association, Washington, DC
3. Ames F. A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. Journal of Mental Science 104 (1958) 972-999
4. Andreasson S., Allebeck P., Engstrom A., and Rydberg U. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet 330 (1987) 1483-1486
5. Arendt M., Rosenberg R., Foldager L., Perto G., and Munk-Jorgensen P. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: Follow-up study of 535 incident cases. British Journal of Psychiatry 187 (2005) 510-515
6. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., and Moffitt T. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal 325 (2002) 1212-1213
7. Arseneault L., Cannon M., Witton J., and Murray R. Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry 184 (2004) 110-117
8. Benichou J. Attributable risk. In: Armitage P., and Colton T. (Eds). Encyclopedia of biostatistics (1998), Wiley, Chichester
9. Boden J.M., Fergusson D.M., and Horwood L.J. Illicit drug use and dependence in a New Zealand birth cohort. Australian and New Zealand Journal of Psychiatry 40 (2006) 156-163
10. Brophy C.J., Norvell N.K., and Kiluk D.J. An examination of the factor structure and convergent and discriminant validity of the SCL-90R in an outpatient clinic population. Journal of Personality Assessment 52 (1988) 334-340
11. Caspi A., Moffitt T., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: Longitudinal evidence of a gene × environment interaction. Biological Psychiatry 57 (2005) 1117-1127
12. Chopra G., and Smith J. Psychotic reactions following cannabis use in East Indians. Archives of General Psychiatry 30 (1974) 24-27
13. Curran C., Byrappa N., and McBride A. Stimulant psychosis: Systematic review. British Journal of Psychiatry 185 (2004) 196-204
14. Daly L.E., and Bourke G.J. Interpretation and uses of medical statistics (2000), Blackwell Science, Oxford
15. Degenhardt L., and Hall W. The association between psychosis and problematic drug use among Australian adults: Findings from the National Survey of Mental Health and Well-being. Psychological Medicine 31 (2001) 659-668
16. Degenhardt, L., Hall, W., & Lynskey, M. (2001). Modelling some possible relationships between cannabis use and psychosis. NDARC Technical Report no. 121. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
17. Degenhardt L., Hall W., and Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence 71 (2003) 37-48
18. de Irala J., Ruiz-Canela M., and Martinez-Gonzalez M. Causal relationship between cannabis use and psychotic symptoms or depression, Should we wait and see? A public health perspective. Medical Science Monitor 11 12 (2005) RA355-358
19. Diamond G., Godley S., Liddle H., Sampl S., Webb C., Tims F., et al. Five outpatient treatment models for adolescent marijuana use: A description of the Cannabis Youth Treatment Interventions. Addiction 97 (2002) 70-83
20. Di Maggio C., Martinez M., Menard J.-F., Petit M., and Thibaut F. Evidence of a cohort effect for age at onset of schizophrenia. American Journal of Psychiatry 158 (2001) 489-492
21. D'Souza D., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y., et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology 29 (2004) 1558-1572
22. Dwyer T., Ponsonby A.-L., Blizzard L., Newman N., and Cochrane J. The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. Obstetrical and Gynecological Survey 50 10 (1995) 704-705
23. Elliot R., Fox C.M., Beltyukova S.A., Stone G.E., Gunderson J., and Zhang X. Deconstructing therapy outcome measurement with rasch analysis of a measure of general clinical distress: The Symptom Checklist-90-Revised. Psychological Assessment 18 (2006) 359-372
24. Favrat B., Menetrey A., Augsburger M., Rothuizen L.E., Appenzeller M., Buclin T., et al. Two cases of "cannabis acute psychosis" following the administration of oral cannabis. BMC Psychiatry 5 17 (2005) 10.1186/1471-1244X-1185-1117
25. Fergusson D.M., Boden J., and Horwood L.J. Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis. Addiction 101 (2006) 556-569
26. Fergusson D.M., and Horwood L. Does cannabis use encourage other forms of illicit drug use?. Addiction 95 (2000) 505-520
27. Fergusson D.M., Horwood L.J., and Ridder E.M. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100 (2005) 354-366
28. Fergusson D.M., Horwood L.J., and Swain-Campbell N.R. Cannabis dependence and psychotic symptoms in young people. Pychological Medicine 33 (2003) 15-21
29. Frisher M., Crome I., Martino O., and Croft P. Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. Schizophrenia Research 113 2-3 (2009) 123-128
30. Hall W. Cannabis use and the mental health of young people. Australian and New Zealand Journal of Psychiatry 40 (2006) 105-113
31. Hall W. Is cannabis use psychotogenic?. Lancet 367 (2006) 193-195
32. Hall W., and Degenhardt L. What are the policy implications of the evidence on cannabis and psychosis?. Canadian Journal of Psychiatry 51 (2006) 566-574
33. Hall W., Degenhardt L., and Teesson M. Cannabis use and psychotic disorders: An update. Drug and Alcohol Review 23 (2004) 433-443
34. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330 (2005) 11
35. Henquet C., Murray R., Linszen D., and van Os J. The environment and schizophrenia: The role of cannabis use. Schizophrenia Bulletin 31 (2005) 608-612
36. Hides L., Dawe S., Kavanagh D., and Young R.M. Psychotic symptoms and cannabis relapse in recent-onset psychosis: Prospective study. British Journal of Psychiatry 189 (2006) 137-143
37. Hill A.B. A short textbook of statistics (1977), Hodder and Stoughton, London
38. Hill A.B., and Hill I.D. Principles of medical statistics. 12th ed. (1991), Edward Arnold, London
39. Johns L.C., Cannon M., Singleton N., Murray R.M., Farrell M., Brugha T., et al. Prevalence and correlates of self-reported psychotic symptoms in the British population. British Journal of Psychiatry 185 (2004) 298-305
40. Johns L.C., and van Os J. The continuity of psychotic experiences in the general population. Clinical Psychology Review 21 (2001) 1125-1141
41. Kavanagh D., Waghorn G., Jenner L., Chant D., Carr V., Evans M., et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample. Schizophrenia Research 66 (2004) 115-124
42. Kendell R., Malcolm D.E., and Adams W. The problem of detecting changes in the incidence of schizophrenia. British Journal of Psychiatry 162 (1993) 212-218
43. Klein D. The flawed basis for FDA post-marketing safety decisions: The example of anti-depressants and children. Neuropsychopharmacology 31 (2006) 689-699
44. Linszen D., Peters B., and de Haan L. Cannabis abuse and the course of schizophrenia. In: Castle D., and Murray R. (Eds). Marijuana and madness: Psychiatry and neurobiology (2004), Cambridge University Press, Cambridge, United Kingdom 119-126
45. Macleod J., and Davey Smith G. Psychosocial factors and public health: A suitable case for treatment?. Journal of Epidemiology and Community Health 57 (2003) 565-570
46. Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M., et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. Lancet 363 (2004) 1579-1588
47. Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M., et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. The Lancet 363 9421 (2004) 1579-1588
48. Macleod J., Smith G., and Hickman M. Does cannabis cause schizophrenia?. Lancet 367 (2006) 1055
49. Mattick R., and McLaren J. Cannabis and psychosis put in perspective. Canadian Journal of Psychiatry 51 9 (2006) 13-14
50. McGorry P.D. The detection and optimal management of early psychosis. In: Lieberman J.A., and Murray R. (Eds). Comprehensive care of schizophrenia: A textbook of clinical management (2001), Informa Health Care, London 153-166
51. McKetin R., McLaren J., Lubman D., and Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 101 (2006) 1473-1478
52. Moore T.H.M., Zammit S., Lingford-Hughes A., Barnes T.R.E., Jones P.B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 370 (2007) 319-328
53. Mortensen P.B., Pedersen C.B., Westergaard T., Wohlfahrt J., Ewald H., Mors O., et al. Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine 340 (1999) 603-608
54. Nunez L., and Gurpegui M. Cannabis-induced psychosis: A cross-sectional comparison with acute schizophrenia. Acta Psychiatrica Scandinavica 105 (2002) 173-178
55. Poulton R., Caspi A., Moffitt T., Cannon M., Murray R., and Harrington H. Children's self-reported psychotic symptoms predict adult schizophreniform disorders: A 15-year longitudinal study. Archives of General Psychiatry 57 (2000) 1053-1058
56. Reinarman C., and Cohen P. Lineaments of cannabis culture: Rules regulating use in Amsterdam and San Francisco. Contemporary Justice Review 10 4 (2007) 393-410
57. Reinarman C., Cohen P., and Kaal H.L. The limited relevance of drug policy: Cannabis in Amsterdam and in San Fransisco. American Journal of Public Health 94 (2004) 836-842
58. Rey J., and Tennant C. Cannabis and mental health. British Medical Journal 325 (2002) 1183-1184
59. Rosenbaum M. "Just say know" to teenagers and marijuana. Journal of HIV/AIDS Prevention in Children and Youth 3 4 (2000) 93-105
60. Semple D.M., McIntosh A.M., and Lawrie S.M. Cannabis as a risk factor for psychosis: Systematic review. Journal of Psychopharmacology 19 (2005) 187
61. Smit F., Bolier L., and Cuijpers P. Cannabis use and the risk of later schizophrenia: A review. Addiction 99 (2004) 425-430
62. Smith G.D., and Ebrahim S. Data dredging, bias, or confounding. British Medical Journal 325 (2002) 1437-1438
63. Solomons K., Neppe V., and Kuyl J. Toxic cannabis psychosis is a valid entity. South African Medical Journal 78 (1990) 476-481
64. Stefanis N.C., Delespaul P., Henquet C., Bakoula C., Stefanis C.N., and van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 99 (2004) 1333-1341
65. Teesson M., Hall W., Lynskey M., and Degenhardt L. Alcohol- and drug-use disorders in Australia: Implications of the national survey of mental health and wellbeing. Australian & New Zealand Journal of Psychiatry 34 2 (2000) 206-213
66. Thomas H. A community survey of adverse effects of cannabis use. Drug and Alcohol Dependence 42 (1996) 201-207
67. Thornicroft G. Cannabis and psychosis: Is there epidemiological evidence for an association?. British Journal of Psychiatry 157 (1990) 25-33
68. Tien A.Y., and Anthony J.C. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease 178 (1990) 473-480
69. Tugwell P., and Haynes B. Assessing claims of causation. In: Haynes B., Sackett D.L., Guyatt G.H., and Tugwell P. (Eds). Clinical epidemiology: How to do clinical practice research (2006), Lippincott Williams and Wilkins, Philadelphia 356-387
70. van Os J., Bak M., Hanssen M., Bijl R., de Graaf R., and Verdoux H. Cannabis use and psychosis: A longitudinal population-based study. American Journal of Epidemiology 156 (2002) 319-327
71. Veen N.D., Selten J.P., van der Tweel I., Feller W., Hoek H.W., and Kahn R.S. Cannabis use and age at onset of schizophrenia. American Journal of Psychiatry 161 (2004) 501-506
72. Wetzler S., and Marlowe D.B. The diagnosis and assessment of depression, mania, and psychosis by self-report. Journal of Personality Assessment 60 (1993) 1-31
73. Wiles N.J., Zammit S., Bebbington P., Singleton N., Meltzer H., and Lewis G. Self-reported psychotic symptoms in the general population. British Journal of Psychiatry 188 (2006) 519-526
74. Wylie A., Scott R., and Burnett S. Psychosis due to "skunk". British Medical Journal 311 (1995) 125
75. Zammit S., Allebeck P., Andreasson S., Lundberg I., and Lewis G. Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. British Medical Journal 325 (2002) 1199-1201
76. Zammit S., Spurlock G., Williams H., Norton N., Williams N., and O'Donovan M.C. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: Interactions with tobacco and cannabis use. British Journal of Psychiatry 191 (2007) 402-407